Japan Pemetrexed Market Size & Outlook, 2025-2033


Japan Pemetrexed Market Insights

  • Based on Reed Intelligence findings, the Japan Pemetrexed Market reached USD 59.08 Million in 2024 and is estimated to attain USD 66.03 Million by 2033.
  • From 2026 to 2033, the Japan market is expected to grow at a steady CAGR of 1.22%.
  • Within the By Application category, Malignant Pleural Mesothelioma dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Malignant Pleural Mesothelioma is forecasted to deliver the fastest growth, positioning it as the most lucrative By Application segment.

Other Key Findings


  • Japan accounted for 2.52% of the global Pemetrexed Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Pemetrexed Market size by 2033.
  • India will be the fastest-growing market in Asia Pacific, projected to achieve USD 94.95 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 59.08 Million
Market Size In 2033 USD 66.03 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.22% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends